Showing results (451-460 of 641) with videos related to
Sort By:
Pageof 65
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2014
Feasibility of treating post-transplantation minimal residual disease in children with acute leukemiaNirali N Shah, Michael J Borowitz, Nancy C Robey, et al.Journal of the National Cancer Institute|September 4, 2020
Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in ChildrenShawn H R Lee, Maoxiang Qian, Wentao Yang, et al.Leukemia|March 14, 2021
Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networksJonathan D Diedrich, Qian Dong, Daniel C Ferguson, et al.Blood|July 1, 2004
Gene expression profiling of pediatric acute myelogenous leukemiaMary E Ross, Rami Mahfouz, Mihaela Onciu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemiaKjeld Schmiegelow, Mette Frandsen Levinsen, Andishe Attarbaschi, et al.The New England Journal of Medicine|April 13, 2012
Outcomes after induction failure in childhood acute lymphoblastic leukemiaMartin Schrappe, Stephen P Hunger, Ching-Hon Pui, et al.The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 10, 2011
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cellsHua Zhang, Yongzhi Cui, Nga Voong, et al.Pageof 65